Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Jewish Rehabilitation Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting.
Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5. For each demand, patients will progress through levels of increasing difficulty according to personalized goals and success criteria.
The project involves the VR-ODT set-up and intervention aimed at improving community walking in stroke survivors, to be implemented and tested within the clinical setting. The set-up comprises of a VR headset (HTC Vive) and an ODT (Infinadeck- to our knowledge the only one in Canada) allowing users to walk at self-selected speed in any direction (360 degrees) in a virtual environment representing a shopping mall in Montreal and nearby streets. Stroke individuals with an altered walking capacity (speed: 0.3 - 0.95m/s) will be recruited from the JRH in- and outpatient programs for 12 consecutive months.
Feasibility (Obj. 1) will be examined using the following measures collated post intervention: number of eligible vs. referred patients and treating clinicians involved; patient and clinician characteristics; adherence to the intervention and adverse events. Perceived mental and physical demands (NASA Tax Load Index), sense of presence (Single- Item Presence Questionnaire) and cybersickness (Simulator Sickness Questionnaire) will also be assessed. Acceptability (Obj. 2) patients and clinicians will be assessed using a Technology Acceptance Model Questionnaire that includes questions related to perceived ease of use and usefulness, as well as with open-ended questions. To optimize uptake and sustainability (Obj. 3), two clinicians (1 occupationnel therapist & 1 physiotherapist) from the JRH stroke program will be trained as clinician-champions (CC) on using the VR-ODT intervention and supporting other clinicians with intervention delivery. The CC, in collaboration with the team, will generate instructional materials (written and video) that detail the intervention, targeted users and step-by-step procedures for clinical use. The CC will also be involved in demonstrations (X2) on the use of the intervention for clinicians. They will be the resource for any question or required assistance with the VR-ODT set-up & intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VR training | Experimental | Participants will engage in a 4-week VR intervention that comprises of 1-hour training sessions, 2 times/week. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Reality Training | Other | The VR intervention involves the intensive practice of community ambulation skills. The training sessions will be performed in a virtual environment. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility: adherence to intervention - number of completed sessions | Training logbook filled by clinicians | 2x/week over the 4-week intervention |
| Feasibility: presence of adverse or undesirable effects during the intervention | Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc). Collected with open-ended questions. | Post-Intervention (week4) |
| Feasibility: Number of participants recruited in each program | Number of early discharged participants vs. outpatient program participants | Pre-intervention (week0) |
| Feasibility: Characteristics of stroke participants: age | Collected via medical charts | Pre-intervention (week 0) |
| Feasibility: Characteristics of stroke participants: sex | Collected via medical charts | Pre-intervention (week 0) |
| Feasibility: Characteristics of stroke participants: gender | Collected via medical charts | Pre-intervention (week 0) |
| Feasibility: Characteristics of stroke participants: walking capacity | Collected via medical charts. According to physiotherapy evaluations, walking capacity is characterized as severely, moderately or mildly affected. | Pre-intervention (week 0) |
Not provided
Not provided
Inclusion Criteria:
Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation Hospital (CISSS Laval) for mobility problems over a period of 6 months will be recruited. They will:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Anouk Lamontagne, PhD | Contact | 450-688-9550 | 84168 | anouk.lamontagne@mcgill.ca |
| Myriamn Villeneuve, Mec | Contact | 514-216-1295 | myriam.villeneuve@mail.mcgill.ca |
| Name | Affiliation | Role |
|---|---|---|
| Anouk Lamontagne, PhD | McGill University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jewish Rehabilitation Hospital | Recruiting | Laval | Quebec | H7V1R2 | Canada |
De-identified individual participant data for all primary and secondary outcome measure will be made available.
Not provided
Data will be available within 6 months of study completion
De-identified data will be deposited in a REDCap database and made available to collaborators. Data may also be made available to other researchers via an institutional data repository that will allow adhering to FAIR principles.
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Intervention study involving a single group, multiple-pre, multiple-post, sequential design
Not provided
Not provided
Not provided
Not provided
|
| Feasibility: Characteristics of stroke participants: cognitive function | Collected via medical charts. According to occupationnal therapy evaluations, cognitive fonction is characterised as severely affected, moderately affected, mildly affected, or intact. | Pre-intervention (week 0) |
| Feasibility: Characteristics of stroke participants: visual-perceptual function | Collected via medical charts. According to occupationnal therapy evaluations, visual-perceptual function is characterised as severely affected, moderately affected, mildly affected, or intact. | Pre-intervention (week 0) |
| Feasibility: Characteristics of clinicians | collected via paper-based questionnaire | Pre-intervention (week0) |
| Feasibility: Number of eligible vs. referred participants | Assessed using the number of participants referred to the study in comparison to the list of admitted patients in the targeted stroke programs. | Post-intervention (week4) |
| Feasibility: Perceived mental and physical demands | Collected using the NASA Tax Load Index. It assesses work load on five 7-point scales. Increments of high, medium and low estimates for each point result in 21 gradations on the scales. | Post-Intervention (week4) |
| Feasibility: Sense of presence | Collected with the Single-Item Presence Questionnaire, a brief measure used to assess a participant's sense of presence in a virtual environment. It consists of one question rated on a 7-point Likert scale, ranging from 1 ("not at all") to 7 ("completely"). | Post-Intervention (week4) |
| Feasibility: Presence of cybersickness | Collected via the Simulator Sickness Questionnaire, used for assessing symptoms of motion or simulator sickness following exposure to virtual environments. It includes 16 symptoms rated on a 4-point scale from 0 ("none") to 3 ("severe"), covering nausea, oculomotor discomfort, and disorientation. | Post-Intervention (week4) |
| Acceptability of the intervention | Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which participants (patients and cliniciens) will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention. | Post-intervention (Week4) |
| Acceptability: Overall experience | Investigated through open-ended questions | Post-Intervention (Week4) |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |